loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2007_224___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Centipharm

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CENTIPHARM Grasse FR (1)

    filter

    01 Gliclazide (1)

    filter

    01 France (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    CENTIPHARM Grasse FR

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Gliclazide

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2007-224 - Rev 00
    Withdrawn by Holder
    Chemical
    2008-11-04
    2013-03-28
    1524
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2007-224 - Rev 00 of Centipharm Grasse Fr

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2007-224 - Rev 00 of Centipharm Grasse Fr 1

    20

    Centipharm Grasse Fr, based in France, is a pharmaceutical company that stands out with its certifications from EDQM and WHO-GMP.

    One of their significant offerings is Gliclazide, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2007-224 - Rev 00

    This Chemical Type CEP, issued on November 04, 2008, remains in force until March 28, 2013, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1524 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY